肝移植治疗门静脉高压症的作用与地位及需要注意的问题  

Effects, status and problems of liver transplantation in the treatment of portal hypertension

作　　者：霍枫[1] 陈建雄[1] 郑于剑[1] 谭晓宇[1] Huo Feng;Chen Jianxiong;Zheng Yujian;Tan Xiaoyu(Department of Hepatobiliary Surgery and Liver Transplantation,General Hospital of Guangzhou Military Command of PLA,Guangzhou 510010,China)

机构地区：[1]广州军区广州总医院肝胆外科、肝脏移植中心,510010

出　　处：《中华消化外科杂志》2018年第10期976-980,共5页Chinese Journal of Digestive Surgery

基　　金：广东省医学科研基金（2014315）

摘　　要：肝移植是治疗门静脉高压症终末期肝病唯一有效的方法。但由于临床上供肝严重匮乏，实际应用时还无法满足庞大的需求。把握好门静脉高压症肝移植的指征和时机，科学处理好移植等待期间或加入移植等待名单前各类并发症，可以避免不必要的肝移植、降低移植等待名单病死率。门静脉高压症肝移植围术期处理有其特殊之处及需要注意的问题，了解并掌握这些特殊之处，处理好这些需要注意的问题，对提高门静脉高压症肝移植成功率、加速肝移植术后康复、降低手术死亡率有着十分重要的意义。Liver transplantation is the only effective treatment for portal hypertension （PHT） and end-stage liver disease. However, great therapeutic needs are far from satisfaction due to extreme shortage of donated livers. Good timing and indicator selection for PHT liver transplantation, and appropriate management of complications before or during on the waiting list, can avoid unnecessary liver transplantation and decrease the mortality rate of patients on waiting list. There are some particularities and issues worthy of attention. Understanding these particularities and handling these issues properly are extremely important to increase the success rate of PHT liver transplantation, enhance the recovery after surgery, and decrease the operative mortality.

关 键 词：门静脉高压症 适应证 肝移植 移植等待 

分 类 号：R657.3[医药卫生—外科学]